Diminished operative risk and improved results following revascularization for atherosclerotic renovascular disease.
Refinements in patient selection, preoperative preparation, and the technical performance of vascular reconstruction have improved the results of revascularization in atherosclerotic renovascular disease. These advances have expanded the eligibility criteria for surgical therapy in this group and now also appear to be favorably influencing late patient survival. This article documents this improved outlook and focuses on the policies in management that have been primarily responsible for its development.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001012:Aorta, Abdominal / Q000601:surgery; D001158:Arteries / Q000601:surgery; D001161:Arteriosclerosis / Q000401:mortality / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D004386:Duodenum / Q000098:blood supply; D005260:Female; D006499:Hepatic Artery / Q000601:surgery; D006801:Humans; D006978:Hypertension, Renovascular / Q000401:mortality / Q000601:surgery*; D007083:Iliac Artery / Q000601:surgery; D008297:Male; D008638:Mesenteric Arteries / Q000601:surgery; D008875:Middle Aged; D012077:Renal Artery / Q000601:surgery; D012078:Renal Artery Obstruction / Q000401:mortality / Q000601:surgery*; D012306:Risk; D012501:Saphenous Vein / Q000637:transplantation; D013164:Splenorenal Shunt, Surgical; D013270:Stomach / Q000098:blood supply